Skip to main content
Erschienen in: Clinical Rheumatology 5/2009

01.05.2009 | Original Article

Risk factors of vertebral fractures in women with systemic lupus erythematosus

verfasst von: Claudia Mendoza-Pinto, Mario García-Carrasco, Hilda Sandoval-Cruz, Margarita Muñoz-Guarneros, Ricardo O. Escárcega, Mario Jiménez-Hernández, Pamela Munguía-Realpozo, Manuel Sandoval-Cruz, Margarita Delezé-Hinojosa, Aurelio López-Colombo, Ricard Cervera

Erschienen in: Clinical Rheumatology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

The aim of the current study was to analyze the role of traditional and systemic lupus erythematosus (SLE)-related risk factors in the development of vertebral fractures. A cross-sectional study was performed in women with SLE attending a single center. A vertebral fracture was defined as a reduction of at least 20% of vertebral body height. Two hundred ten patients were studied, with median age of 43 years and median disease duration of 72 months. Osteopenia was present in 50.3% of patients and osteoporosis in 17.4%. At least one vertebral fracture was detected in 26.1%. Patients with vertebral fractures had a higher mean age (50 ± 14 vs. 41 ± 13.2 years, p = 0.001), disease damage (57.1% vs. 34.4%, p = 0.001), lower bone mineral density (BMD) at the total hip (0.902 ± 0.160 vs. 982 ± 0.137 g/cm2, p = 0.002), and postmenopausal status (61.9% vs. 45.3%, p = 0.048). Stepwise logistic regression analysis revealed that only age (p = 0.001) and low BMD at the total hip (p = 0.007) remained as significant factors for the presence of vertebral fracture. The high prevalence of vertebral fractures in the relatively young population implies that more attention must be paid to detect and treat vertebral fractures.
Literatur
1.
Zurück zum Zitat Croker JA, Kimberly RP (2005) SLE: challenges and candidates in human disease. Trends Immunol 26:580–586PubMedCrossRef Croker JA, Kimberly RP (2005) SLE: challenges and candidates in human disease. Trends Immunol 26:580–586PubMedCrossRef
2.
Zurück zum Zitat Galdman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369CrossRef Galdman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369CrossRef
3.
Zurück zum Zitat Bultink I, Lems W, Kostense P, Dijkmans BAC, Voskuyl AE (2005) Prevalence of risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 54:2044–2050CrossRef Bultink I, Lems W, Kostense P, Dijkmans BAC, Voskuyl AE (2005) Prevalence of risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 54:2044–2050CrossRef
4.
Zurück zum Zitat Borba VZC, Matos PG, da Silva Vianna PR, Fernandes A, Sato EI, Lazaretti-Castro M (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529–533PubMedCrossRef Borba VZC, Matos PG, da Silva Vianna PR, Fernandes A, Sato EI, Lazaretti-Castro M (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529–533PubMedCrossRef
6.
Zurück zum Zitat Cooper C, Atkinson EJ, O’Fallon WM, Melton LJIII (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota. J Bone Miner Res 7:221–227PubMed Cooper C, Atkinson EJ, O’Fallon WM, Melton LJIII (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota. J Bone Miner Res 7:221–227PubMed
7.
Zurück zum Zitat Melton LJIII, Atkinson EJ, Cooper C, O’Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10(3):214–221PubMedCrossRef Melton LJIII, Atkinson EJ, Cooper C, O’Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10(3):214–221PubMedCrossRef
8.
Zurück zum Zitat Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14(5):821–828PubMedCrossRef Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14(5):821–828PubMedCrossRef
9.
Zurück zum Zitat Oleksik A, Lips P, Dawson A, Minsshall ME, Shen W, Cooper C (2000) Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 15:1384–1392PubMedCrossRef Oleksik A, Lips P, Dawson A, Minsshall ME, Shen W, Cooper C (2000) Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 15:1384–1392PubMedCrossRef
10.
Zurück zum Zitat Nevitt MC, Cumming SR, Stone KL et al (2005) Risk factors for a first-incident radiographic vertebral fracture in women > or =65 years of age: the study of osteoporotic fractures. J Bone Miner Res 20(1):131–140PubMed Nevitt MC, Cumming SR, Stone KL et al (2005) Risk factors for a first-incident radiographic vertebral fracture in women > or =65 years of age: the study of osteoporotic fractures. J Bone Miner Res 20(1):131–140PubMed
11.
Zurück zum Zitat Hasserius R, Karlsson B, Jonsson B et al (2005) Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly—a 12- and 22-year follow-up of 257 patients. Calcif Tissue Int 76:235–242PubMedCrossRef Hasserius R, Karlsson B, Jonsson B et al (2005) Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly—a 12- and 22-year follow-up of 257 patients. Calcif Tissue Int 76:235–242PubMedCrossRef
12.
Zurück zum Zitat Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O (2003) Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int 14:61–68PubMedCrossRef Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O (2003) Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int 14:61–68PubMedCrossRef
13.
Zurück zum Zitat Genant HK, Wu CH, Van Kuijk C, Nevitt MC (1993) Vertebral fractures assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef Genant HK, Wu CH, Van Kuijk C, Nevitt MC (1993) Vertebral fractures assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef
14.
Zurück zum Zitat Stone KL, Seeley DG, Lui LY, Osteoporotic Fractures Research Group et al (2003) BMD at multiple sites and risk of fractures of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18:1947–1954PubMedCrossRef Stone KL, Seeley DG, Lui LY, Osteoporotic Fractures Research Group et al (2003) BMD at multiple sites and risk of fractures of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18:1947–1954PubMedCrossRef
15.
Zurück zum Zitat Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook PN (2000) Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med 160:2917–2922PubMedCrossRef Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook PN (2000) Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med 160:2917–2922PubMedCrossRef
16.
Zurück zum Zitat Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801–806PubMedCrossRef Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801–806PubMedCrossRef
17.
Zurück zum Zitat Selby PL, Halsey JP, Adams KR et al (2000) Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 15:952–956PubMedCrossRef Selby PL, Halsey JP, Adams KR et al (2000) Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 15:952–956PubMedCrossRef
18.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF (1982) The 1982 revised criteria of the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF (1982) The 1982 revised criteria of the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
19.
Zurück zum Zitat Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D (1992) Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 19:1551–1558PubMed Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D (1992) Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 19:1551–1558PubMed
20.
Zurück zum Zitat Kanis JA, Gluer CC (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisor, International Osteoporosis Foundation. Osteoporos Int 11:192–202PubMedCrossRef Kanis JA, Gluer CC (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisor, International Osteoporosis Foundation. Osteoporos Int 11:192–202PubMedCrossRef
21.
Zurück zum Zitat Clark P, Cons-Molina F, Deleze M, Ragi S, Haddock L, Zanchetta JR, Jaller JJ, Palermo L, Talavara JO, Messina DO, Morales-Torres J, Salmerpn J, Navarrete A, Suarez E, Pérez CM, Cummings SR (2009) The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS. Osteoporos Int 20:275–282PubMedCrossRef Clark P, Cons-Molina F, Deleze M, Ragi S, Haddock L, Zanchetta JR, Jaller JJ, Palermo L, Talavara JO, Messina DO, Morales-Torres J, Salmerpn J, Navarrete A, Suarez E, Pérez CM, Cummings SR (2009) The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS. Osteoporos Int 20:275–282PubMedCrossRef
22.
Zurück zum Zitat Orstavik RE, Haugeberg G, Uhlig T, Mowinckel P, Kvien TK, Falch JA, Halse JI (2004) Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities. Ann Rheum Dis 63(8):945–951PubMedCrossRef Orstavik RE, Haugeberg G, Uhlig T, Mowinckel P, Kvien TK, Falch JA, Halse JI (2004) Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities. Ann Rheum Dis 63(8):945–951PubMedCrossRef
23.
Zurück zum Zitat Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticosteroids: potential mechanism of their deleterious effects on bone. J Clin Invest 102:274–282PubMedCrossRef Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticosteroids: potential mechanism of their deleterious effects on bone. J Clin Invest 102:274–282PubMedCrossRef
24.
Zurück zum Zitat Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, Giorgino R, Moro L, Giustina A (2006) High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2):253–259PubMedCrossRef Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, Giorgino R, Moro L, Giustina A (2006) High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2):253–259PubMedCrossRef
Metadaten
Titel
Risk factors of vertebral fractures in women with systemic lupus erythematosus
verfasst von
Claudia Mendoza-Pinto
Mario García-Carrasco
Hilda Sandoval-Cruz
Margarita Muñoz-Guarneros
Ricardo O. Escárcega
Mario Jiménez-Hernández
Pamela Munguía-Realpozo
Manuel Sandoval-Cruz
Margarita Delezé-Hinojosa
Aurelio López-Colombo
Ricard Cervera
Publikationsdatum
01.05.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 5/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1105-3

Weitere Artikel der Ausgabe 5/2009

Clinical Rheumatology 5/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.